1. Home
  2. CETX vs PTIX Comparison

CETX vs PTIX Comparison

Compare CETX & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemtrex Inc.

CETX

Cemtrex Inc.

HOLD

Current Price

$4.27

Market Cap

3.5M

Sector

Technology

ML Signal

HOLD

Logo Protagenic Therapeutics Inc.

PTIX

Protagenic Therapeutics Inc.

HOLD

Current Price

$1.66

Market Cap

3.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CETX
PTIX
Founded
1998
1994
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.2M
IPO Year
1998
2016

Fundamental Metrics

Financial Performance
Metric
CETX
PTIX
Price
$4.27
$1.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.5M
108.3K
Earning Date
12-29-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$76,095,551.00
N/A
Revenue This Year
$19.77
N/A
Revenue Next Year
$15.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.50
N/A
52 Week Low
$2.50
$1.46
52 Week High
$55.50
$14.28

Technical Indicators

Market Signals
Indicator
CETX
PTIX
Relative Strength Index (RSI) 52.51 31.07
Support Level $2.50 $1.46
Resistance Level $9.70 $2.38
Average True Range (ATR) 0.96 0.19
MACD 0.24 -0.01
Stochastic Oscillator 25.00 21.80

Price Performance

Historical Comparison
CETX
PTIX

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Share on Social Networks: